Colony Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
HCMT
AIG
AWM
Colony Group's BTAL Position: Q1 2016 in Review
Colony Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2016, closing a stake of 39 shares — an estimated $1K sold.
Colony Group first reported a position in BTAL in Q4 2013 and held it in 9 quarters. The position peaked at $5K in Q1 2015. 8 funds tracked by Wall St. Rank hold BTAL as of Q1 2016.
- Colony Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2016 after selling out during the quarter.
- Colony Group sold 39 AGF US Market Neutral Anti-Beta Fund shares in Q1 2016, an estimated $1K.
- Colony Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2013 and held it in 9 quarters.
- Colony Group's AGF US Market Neutral Anti-Beta Fund position peaked at $5K in Q1 2015.
- 8 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2016.
Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.